Cardiovascular risk factors associated with clinically isolated and diffuse atherosclerosis in Spanish patients with coronary artery disease

European Journal of Clinical Investigation

Volumn 28, Issue 8, 1998, Pages 643-650

  Meco, J F ^a   Pinto X ^a,c   Escriba J M ^a,b   Vela, M ^a   Jara, F ^a   Pallares C ^a   Castineiras M J ^a   Pujol, R ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Direccio d'Atencio Primaria   (Spain)

^c Unitat d'Arteriosclerosi   (Spain)

Author keywords

Atherogenic ratio; Cardiovascular risk factors; Coronary artery disease; Diffuse atherosclerosis; Hypoalphalipoproteinaemia; Isolated atherosclerosis

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SPAIN;

AGED; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; BODY MASS INDEX; CEREBROVASCULAR DISORDERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SPAIN;

EID: 0031821453     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00350.x     Document Type: Article

References (29)

1. Ellekjaer EF, Wyller TB, Sverre JM, Holmen J. Lifestyle factors and risk of cerebral infarction. Stroke 1992; 23: 829-34.
2. Wilt TJ, Rubbins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ. for the Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Arch Intern Med 1996; 156: 1181-8.
3. Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ. for the Coronary Artery Surgery Study (CASS) Investigators. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. J Am Coll Cardiol 1994; 23: 1091-5.
4. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.
5. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982; 28: 1379-88.
6. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
8. Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-6.
9. Wilt TJ, Davis BR, Meyers DG, Rouleau JL, Sacks FM. Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) Study. Angiology 1996; 47: 533-41.
10. MacMahon SW, Cutler JA, Neaton JD et al. Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. J Hypertens 1986; 4 (Suppl. 6): S14-17.
11. Roberts WC. The hypertensive diseases. Evidence that systemic hypertension is a greater risk factor to the development of other cardiovascular diseases than previously suspected. Am J Med 1975; 59: 523-32.
12. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 1985; 34: 938-41.
13. Vigorito C, Bettochi S, Bonzani G et al. Severity of coronary artery disease in patients with diabetes mellitus. Angiographic study of 34 diabetic and 120 nondiabetic patients. Am Heart J 1980; 100: 782-7.
14. Fielding PE, Fielding CJ, Havel RJ, Kane JP, Tun P. Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma. J Clin Invest 1983; 71: 449-60.
15. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990; 1044: 275-83.
16. Yui Y, Aoyama T, Morishita H, Takahashi M, Takatsu Y, Kawai C. Serum prostacyclin stabilizing factor is identical to apolipoprotein A-1 (Apo A-I). A novel function of Apo A-1. J Clin Invest 1988; 82: 803-7.
17. Fleisher LN, Tall AR, Witte LD, Miller RW, Cannon PJ. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem 1982; 257: 6653-5.
18. Kuhn FE, Mohler ER, Satler LF, Reagan K, Lu DY, Rackley CE. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am J Cardiol 1991; 68: 1425-30.
19. Ko Y, Haring R, Stiebler H, Wieczorek AJ, Vetter H, Sachinidis A. High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Atherosclerosis 1993; 99: 253-9.
20. Saku K, Ahmad M, Glas-Greenwalt P, Kashyap ML. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man. Thromb Res 1985; 39: 1-8.
21. Pintó X, Martínez Matos JA, Fiol C et al. Alteraciones lipoproteicas en los pacientes con accidente vascular cerebral transitorio. Med Clin 1985; 85: 435-8.
22. Hatcher C, Markle HV, FitzGibbon GM, Burton J. Relationships between high density lipoprotein cholesterol (HDLC) and the severity of coronary artery disease (CAD) as determined by angiography: evaluation of HDLC as a laboratory test [Abstract]. Clin Chem 1980; 26: 965-6.
23. Naito HK. Association between serum HDL-cholesterol concentration and severity of coronary artery disease (CAD) determined by cineangiography [Abstract]. Clin Chem 1980; 26: 966.
24. Pomrehn P, Duncan B, Weissfeld L et al. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence. Circulation 1986; 73: 1100-7.
25. Seeger JM, Silverman SH, Flynn TC et al. Lipid risk factors in patients requiring arterial reconstruction. J Vasc Surg 1989; 10: 418-24.
26. Fiol C, Pintó X, Santamaría P, Simeon JM, Capdevila JM. Anomalous apoprotein E isoforms in peripheral arteriopathy. Clin Chem 1987; 33: 417.
27. Laakso M, Pyörälä K. Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease. Atherosclerosis 1988; 74: 55-63.
28. Pedro-Botet J, Sentí M, Nogués X, Rubies-Prat J, Vidal-Barraquer F. Alteraciones de las lipoproteínas de alta densidad en la enfermedad vascular periférica. Med Clin 1991; 96: 493-5.
29. Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993; 22: 933-40.